Perioperatieve pijnbestrijding en uitkomsten na pancreasresecties in het LUMC : Perioperative analgesic management and outcomes in patients undergoing pancreatectomy in a Dutch tertiary referral center
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2023) vom: 03. Apr. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Niederländisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2017-11-22, Last updated: 2023-04-06 |
|---|
| ICTRP ID: |
NTR6871 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
WHO004840488 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WHO004840488 | ||
| 003 | DE-627 | ||
| 005 | 20230425174533.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210507s2023 xx |||||o 00| ||dut c | ||
| 035 | |a (DE-627)WHO004840488 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NTR6871 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NL6701 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)Commissie Medische Ethiek | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)Leids Universitair Medische Centrum : G12.059 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a dut | ||
| 245 | 1 | 0 | |a Perioperatieve pijnbestrijding en uitkomsten na pancreasresecties in het LUMC |b Perioperative analgesic management and outcomes in patients undergoing pancreatectomy in a Dutch tertiary referral center |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2017-11-22, Last updated: 2023-04-06 | ||
| 650 | 4 | |a Medical Condition: Epidural analgesia (EA) is the current golden standard for perioperative pain management in most abdominal surgery. However, as demonstrated by the variety of reported use of EA (ranging approximately from 10%-84%), the golden standard in patients undergoing pancreatectomy has yet to be determined.The reported benefits from EA in abdominal surgery might not apply to patients undergoing pancreatectomy. <br /> In contrast to the beneficial reported effect on postoperative complications of EA in abdominal surgery, recent studies described an adverse effect of EA on postoperative complications, Intensive Care Unit (ICU) admissions and length of hospital stay (LOS). Although some studies reported a (marginally) better postoperative pain control in patient with EA compared to other analgesic management options, detailed reports on pain outcomes after pancreatectomy are sparse.<br />The aim of this study is to evaluate the current practice of analgesic management and outcomes in patients undergoing pancreatectomy in our tertiary referral center. | |
| 650 | 4 | |a Study Type: Observational non invasive | |
| 650 | 4 | |a Recruitment Status: Recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2023) vom: 03. Apr. |
| 773 | 1 | 8 | |g year:2023 |g day:03 |g month:04 |
| 856 | 4 | 0 | |u https://www.onderzoekmetmensen.nl/en/trial/22401 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 03 |c 04 | ||